Wednesday, 7 June 2017

Unichem Lab receives EIR from USFDA for Ghaziabad plant


Leading pharma company, Unichem Laboratories Limited has said that the company's formulations manufacturing facility at Ghaziabad has received an Establishment Inspection Report (EIR) from the USFDA. “This receipt indicates the successful closure of the inspection and the queries raised during the audit (Form 483). The inspection has now been closed by the USFDA. The inspection was carried out between 24th Feb 2017 to 3rd March 2017,” the company said in a filing to the Bombay Stock Exchange. Recommendations on Share market and more go through our website from here link below and let us to know you more: http://www.ripplesadvisory.com/nifty-future-.php

No comments:

Post a Comment

Note: only a member of this blog may post a comment.